Causes of death in a post-mortem series of ALS patients.
about
A comprehensive review of amyotrophic lateral sclerosisInterleukin-1 Antagonist Anakinra in Amyotrophic Lateral Sclerosis--A Pilot StudyIs survival improved by the use of NIV and PEG in amyotrophic lateral sclerosis (ALS)? A post-mortem study of 80 ALS patients.Infection of the central nervous system, sepsis and amyotrophic lateral sclerosis.CNS-targeted glucocorticoid reduces pathology in mouse model of amyotrophic lateral sclerosisSevere respiratory changes at end stage in a FUS-induced disease state in adult rats.Risk of sepsis in patients with amyotrophic lateral sclerosis: a population-based retrospective cohort study in Taiwan.ALS with respiratory onset: clinical features and effects of non-invasive ventilation on the prognosis.Management of respiratory symptoms in ALS.Is there a case for diaphragm pacing for amyotrophic lateral sclerosis patients?Respiratory therapies for amyotrophic lateral sclerosis: a primer.Ventilatory control in ALS.The role of radiation therapy in the management of sialorrhea: A systematic review.Proteomic studies in the discovery of cerebrospinal fluid biomarkers for amyotrophic lateral sclerosis.Trends in Research Literature Describing Dysphagia in Motor Neuron Diseases (MND): A Scoping Review.A mapping review of international guidance on the management and care of amyotrophic lateral sclerosis (ALS).A preliminary randomized trial of the mechanical insufflator-exsufflator versus breath-stacking technique in patients with amyotrophic lateral sclerosis.High frequency spinal cord stimulation-New method to restore cough.Cardiac Findings in Amyotrophic Lateral Sclerosis: A Magnetic Resonance Imaging Study.Use of respiratory function tests to predict survival in amyotrophic lateral sclerosis.Monitoring respiratory muscle strength assists in early diagnosis of respiratory dysfunction as opposed to the isolated use of pulmonary function evaluation in amyotrophic lateral sclerosis.Motoneuron Disease: Clinical.Ability of pulmonary function decline to predict death in amyotrophic lateral sclerosis patients.Plasma level of club-cell (CC-16) predicts outcome in amyotrophic lateral sclerosis.Computational Analysis of Pharyngeal Swallowing Mechanics in Patients with Motor Neuron Disease: A Pilot Investigation.Noninvasive ventilation in amyotrophic lateral sclerosis: effects on sleep quality and quality of life.Thiamine deficiency in amyotrophic lateral sclerosis.Epigenetic Mechanisms of Gene Regulation in Amyotrophic Lateral Sclerosis.Causes and places of death of patients with amyotrophic lateral sclerosis in south-west China.Venous thromboembolism after diaphragm pacing in amyotrophic lateral sclerosis.Gray matter and white matter changes in non-demented amyotrophic lateral sclerosis patients with or without cognitive impairment: A combined voxel-based morphometry and tract-based spatial statistics whole-brain analysis.Hypoglossal Motor Neuron Death Via Intralingual CTB-saporin (CTB-SAP) Injections Mimic Aspects of Amyotrophic Lateral Sclerosis (ALS) Related to DysphagiaValidation of robust tools to measure sialorrhea in amyotrophic lateral sclerosis: A study in a large French cohortTHEME 1 IMPROVING DIAGNOSIS, PROGNOSIS AND DISEASE PROGRESSIONMachine Learning Reveals Protein Signatures in CSF and Plasma Fluids of Clinical Value for ALSMaximizing the Survival of Amyotrophic Lateral Sclerosis Patients: Current Perspectives
P2860
Q26775401-1A3C1D59-F9D8-4117-B151-0BE3269D1087Q28550089-1B76EC55-FA30-4938-A44D-E25BE59DD3F0Q33719041-88E04B0E-ABD8-45EF-923E-A0B2D66DA83BQ34117922-5F953913-2FCE-47E1-8E2A-B6B4E546257CQ34500059-CB095BEA-B622-4BB6-B4DD-168947C93FEEQ36177447-635EE6EC-A374-45BD-AD24-15E0DC58E117Q37598197-F1C21690-EDDA-44C3-946A-C0500001ABE5Q37650353-62DC598E-E19F-4BB4-BD6A-8E6EDD705022Q37810000-23C98F19-B2A8-4B21-9456-5C7429F296A6Q38013222-40070635-13B1-46B7-8455-0AE663F57D13Q38036088-4C54E2D9-7735-4D41-AD74-763467050244Q38108422-2FAACB46-2FBE-45D7-94B3-342862046A37Q38543693-644B0D72-D459-4F55-934C-FE519DAB4D33Q38643847-ACCB0230-CED1-47F8-AA75-20E73D726F53Q38700978-F6F655C2-C453-43D0-A2F6-96E691992D5EQ38808215-E7D31315-93C4-435F-AD93-6297A5A382FDQ40770831-075033F0-623D-47D8-92C4-671D017F5221Q41657111-E01CEA7A-FE13-48DA-8DD2-E49A4CBF331CQ42288873-E6108242-135F-4933-A5C2-468E56089676Q43492209-1F1C25DA-4577-4D40-8056-7ED93EF9482FQ43701400-443AEEC6-D852-40CB-8CCA-C682F63D826CQ45869420-36FF92C4-AE00-4818-8EB1-BBF32DC9B9BFQ47316807-BDFD15BE-C382-4B59-9FC2-AB44D2F3B379Q47608879-364F1B9E-D10D-4E90-9AE0-C0ABA473F938Q47754744-EE951D90-5E79-457E-8A00-E468606B2660Q47766295-44C00CE0-C099-4208-97E5-DF8EBB739E06Q48216664-6CFB702E-C327-4587-919F-E3059817934DQ50993029-6ADA8707-BE00-4814-8378-F32AFF30392AQ51038644-B270EB07-83BE-40F4-BE84-64B7E61A38C4Q51704828-4F14F875-6A13-48EC-928E-11CA8B7E395BQ52098090-09613C54-D745-4938-B8ED-42F63D3B9B49Q57465334-99D74687-BF21-48D1-9144-F413E0E5D5F3Q58280431-5A63C5F6-3777-4AA0-9B03-90FBF0F4CC96Q58298523-FCA0A2F7-246C-49B4-9EB9-95599EDD4616Q58612356-2E0D7B3F-67C4-4E2C-AAF6-35DAF1694462Q58787868-3AF52C61-13E8-4017-A89B-9D62D52ECF2F
P2860
Causes of death in a post-mortem series of ALS patients.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年学术文章
@wuu
2008年学术文章
@zh
2008年学术文章
@zh-cn
2008年学术文章
@zh-hans
2008年学术文章
@zh-my
2008年学术文章
@zh-sg
2008年學術文章
@yue
2008年學術文章
@zh-hant
name
Causes of death in a post-mortem series of ALS patients.
@en
Causes of death in a post-mortem series of ALS patients.
@nl
type
label
Causes of death in a post-mortem series of ALS patients.
@en
Causes of death in a post-mortem series of ALS patients.
@nl
prefLabel
Causes of death in a post-mortem series of ALS patients.
@en
Causes of death in a post-mortem series of ALS patients.
@nl
P2093
P2860
P50
P1476
Causes of death in a post-mortem series of ALS patients.
@en
P2093
Danielle Seilhean
François Salachas
Gaëlle Bruneteau
Jean-Jacques Hauw
Nadine le Forestier
P2860
P356
10.1080/17482960701656940
P577
2008-01-01T00:00:00Z